Artículo de revista
Seroprevalence of Human Herpesvirus-8 in Blood Donors From Different Geographical Regions of Argentina, Brazil, and Chile
Fecha
2004Registro en:
Journal of Medical Virology 72:661–667 (2004)
DOI 10.1002/jmv.20029
Autor
Pérez, Celeste
Tous, Mónica
Gallego, Sandra
Zala, Norma
Rabinovich, Óscar
Garbiero, Susana
Martínez Galofre, María José
Gusmao Cunha, Andrea Mendonca
Camino, Sofía
Cámara, Alicia
Botelho Costa, Sandra Cecilia
Larrondo, Milton
Francalancia, Verónica
Landreau, Fernando
Bartomioli, Miguel Angel
Institución
Resumen
Human herpesvirus-8 (HHV-8) causes Kaposi’s
sarcoma (KS) and lymphoproliferative disorders
in both HIV-infected and uninfected patients.
HHV-8 has a worldwide occurrence but infection
rates vary according to a combination of geographic
and behavioral risks. The main transmission
route seems to be sexual, nevertheless,
nasal secretions, saliva, blood, and organ graft
have been proposed. HHV-8 was postulated as a
new infectious agent for screening in blood
donors. The aim of this study was to evaluate
the prevalence of antibodies against HHV-8
antigens in blood donors of South America.
Serum samples from 2,470 blood donors from
Argentina, Brazil, and Chile corresponding to five
geographic regions were studied by indirect
immunofluorescence assay (IFA). Seroprevalence
rate was 3.7% (92/2,470; 95% CI 2.9–4.5) in
the entire blood donor population distributed
as follows: Argentina, 4.0% (Buenos Aires city,
4.3%; Bahia Blanca, 2.4%; and Co´ rdoba, 4.0%),
Campinas (Brazil), 2.8%; and Santiago de Chile,
3.0%. There was no difference (P>0.05) between
men and women or age related, except in Brazil
where positive cases were 30–49-year-old males.
The present study, which includes different
geographical areas of multiple countries from
South America, has not been done before. The
results show similar prevalence rates among the
studied zones corresponding to low-prevalence
regions. South America is a large sub-continent
with a wide spectrum of population and geographical
characteristics, thus, more HHV-8 prevalence
studies should be necessary to establish
possible regional differences.